These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 25283825)

  • 1. [Acute encephalitis with refractory partial status epilepticus treated with early immunotherapies including plasma exchange: a case report].
    Yamamoto D; Uchiyama T; Bunai T; Sato K; Shimizu T; Tanaka K; Ohashi T
    Rinsho Shinkeigaku; 2014; 54(9):715-20. PubMed ID: 25283825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Five cases of new onset refractory status epilepticus (NORSE) syndrome: outcomes with early immunotherapy.
    Gall CR; Jumma O; Mohanraj R
    Seizure; 2013 Apr; 22(3):217-20. PubMed ID: 23333762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Successful combination immunotherapy of anti-gamma aminobutyric acid (GABA)
    Fukami Y; Okada H; Yoshida M; Yamaguchi K
    Rinsho Shinkeigaku; 2017 Aug; 57(8):436-440. PubMed ID: 28740064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe refractory status epilepticus owing to presumed encephalitis.
    Kramer U; Shorer Z; Ben-Zeev B; Lerman-Sagie T; Goldberg-Stern H; Lahat E
    J Child Neurol; 2005 Mar; 20(3):184-7. PubMed ID: 15832606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term and Strong Immunotherapy to Treat Anti-N-Methyl- D-Aspartate Receptor Encephalitis with Refractory Status Epilepticus.
    Lee LH; Lu CJ
    Acta Neurol Taiwan; 2016 Sep; 25(3):99-103. PubMed ID: 27854088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of cryptogenic new-onset refractory status epilepticus (NORSE) in which cerebrospinal fluid IL-6 was elevated with increased seizure frequency early in the disease: a case report].
    Nakada R; Terasawa Y; Sato T; Takatsu H; Kaito N; Iguchi Y
    Rinsho Shinkeigaku; 2023 Dec; 63(12):843-846. PubMed ID: 37989289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment responsive GABA(B)-receptor limbic encephalitis presenting as new-onset super-refractory status epilepticus (NORSE) in a deployed U.S. soldier.
    Hainsworth JB; Shishido A; Theeler BJ; Carroll CG; Fasano RE
    Epileptic Disord; 2014 Dec; 16(4):486-93. PubMed ID: 25465280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Febrile infection-related epilepsy syndrome (FIRES) with super-refractory status epilepticus revealing autoimmune encephalitis due to GABA
    Caputo D; Iorio R; Vigevano F; Fusco L
    Eur J Paediatr Neurol; 2018 Jan; 22(1):182-185. PubMed ID: 29203057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A case of new-onset refractory status epilepticus (NORSE) with an autoimmune etiology].
    Ishikura T; Okuno T; Araki K; Takahashi MP; Watabe K; Mochizuki H
    Rinsho Shinkeigaku; 2015; 55(12):909-13. PubMed ID: 26511026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Efficacy of potassium bromide in the treatment of drug-resistant epilepsy: a case of new-onset refractory status epilepticus].
    Takei J; Takei R; Nozuma S; Nakahara K; Watanabe O; Takashima H
    Rinsho Shinkeigaku; 2016 Nov; 56(11):759-763. PubMed ID: 27773903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New-onset refractory status epilepticus (NORSE)--The potential role for immunotherapy.
    Khawaja AM; DeWolfe JL; Miller DW; Szaflarski JP
    Epilepsy Behav; 2015 Jun; 47():17-23. PubMed ID: 26010959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A favorable outcome of intensive immunotherapies for new-onset refractory status epilepticus (NORSE).
    Kodama S; Arai N; Hagiwara A; Kimura A; Takeuchi S
    J Intensive Care; 2018; 6():43. PubMed ID: 30083346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New onset refractory status epilepticus: State of the art.
    Périn B; Szurhaj W
    Rev Neurol (Paris); 2022; 178(1-2):74-83. PubMed ID: 35031143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Febrile infection-related epilepsy syndrome (FIRES) treated with immunomodulation in an 8-year-old boy and review of the literature.
    Alparslan C; Kamit-Can F; Anıl AB; Olgaç-Dündar N; Çavuşoğlu D; Göç Z
    Turk J Pediatr; 2017; 59(4):463-466. PubMed ID: 29624228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case of new onset refractory status epilepticus in a U.S. traveler with Japanese encephalitis.
    Osbourn SR; Ryan KE; Cannard KR; Ma Y
    J Neuroimmunol; 2023 Oct; 383():578193. PubMed ID: 37659268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rhythmic delta activity represents a form of nonconvulsive status epilepticus in anti-NMDA receptor antibody encephalitis.
    Kirkpatrick MP; Clarke CD; Sonmezturk HH; Abou-Khalil B
    Epilepsy Behav; 2011 Feb; 20(2):392-4. PubMed ID: 21190901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New onset refractory status epilepticus (NORSE).
    Sculier C; Gaspard N
    Seizure; 2019 May; 68():72-78. PubMed ID: 30482654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Febrile Infection-Related Epilepsy Syndrome (FIRES): An Overview of Treatment and Recent Patents.
    Hon KL; Leung AKC; Torres AR
    Recent Pat Inflamm Allergy Drug Discov; 2018; 12(2):128-135. PubMed ID: 29745347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of intravenous immunoglobulin and steroid pulse therapy improves outcomes of febrile refractory status epilepticus.
    Lin JJ; Wang Y; Lan SY; Chan OW; Hsia SH; Chou ML; Hung PC; Hsieh MY; Chou IJ; Wang HS; Lin KL;
    Epilepsy Res; 2018 May; 142():100-105. PubMed ID: 29609074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-N-methyl-D-aspartate receptor encephalitis with favorable outcome despite prolonged status epilepticus.
    Finné Lenoir X; Sindic C; van Pesch V; El Sankari S; de Tourtchaninoff M; Denays R; Hantson P
    Neurocrit Care; 2013 Feb; 18(1):89-92. PubMed ID: 23090840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.